Miglustat
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171975This classification denotes a glucosidase inhibitor with the molecular formula C10H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ADN3S497AZ, chemically known as 3,4,5-piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2r,3r,4r,5s)- but generally known as miglustat, which bears US NIH Compound Identifier 51634. European Medicines Agency schedules Miglustat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20049. The term MIGLUSTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., No. 1.2002, List 47). World Health Organization schedules miglustat in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule Miglustat under HS 29333999 and SITC 51574. As of Q4 2014, MIGLUSTAT remains the US FDA Preferred Term for this commodity. Miglustat bears US NLM identifiers UMLS ID C1321596 and NCI Concept Code C1222. SMILES: CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.